Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TOCILIZUMAB Cause Rheumatoid factor positive? 4,065 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 4,065 reports of Rheumatoid factor positive have been filed in association with TOCILIZUMAB (Tocilizumab-anoh). This represents 4.1% of all adverse event reports for TOCILIZUMAB.

4,065
Reports of Rheumatoid factor positive with TOCILIZUMAB
4.1%
of all TOCILIZUMAB reports
1,278
Deaths
1,589
Hospitalizations

How Dangerous Is Rheumatoid factor positive From TOCILIZUMAB?

Of the 4,065 reports, 1,278 (31.4%) resulted in death, 1,589 (39.1%) required hospitalization, and 1,483 (36.5%) were considered life-threatening.

Is Rheumatoid factor positive Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TOCILIZUMAB. However, 4,065 reports have been filed with the FAERS database.

What Other Side Effects Does TOCILIZUMAB Cause?

Drug ineffective (32,342) Rheumatoid arthritis (20,652) Pain (18,384) Off label use (18,256) Arthralgia (15,536) Joint swelling (14,831) Fatigue (13,802) Rash (12,327) Drug intolerance (11,952) Contraindicated product administered (11,547)

What Other Drugs Cause Rheumatoid factor positive?

METHOTREXATE (4,237) ABATACEPT (4,041) ADALIMUMAB (4,020) LEFLUNOMIDE (3,865) RITUXIMAB (3,793) HYDROXYCHLOROQUINE (3,791) INFLIXIMAB (3,584) ETANERCEPT (3,568) SULFASALAZINE (3,306) CERTOLIZUMAB PEGOL (3,207)

Which TOCILIZUMAB Alternatives Have Lower Rheumatoid factor positive Risk?

TOCILIZUMAB vs TOCILIZUMAB-AAZG TOCILIZUMAB vs TOCOPHEROL TOCILIZUMAB vs TOFACITINIB TOCILIZUMAB vs TOFERSEN TOCILIZUMAB vs TOLNAFTATE

Related Pages

TOCILIZUMAB Full Profile All Rheumatoid factor positive Reports All Drugs Causing Rheumatoid factor positive TOCILIZUMAB Demographics